IDH clonal heterogeneity segregates a subgroup of non-1p/19q codeleted gliomas with unfavourable clinical outcome.
Shangyi LuoShiwei ZhuJianlong LiaoYajing ZhangXiaobo HouTao LuoErjie ZhaoJinyuan XuLin PangXin LiangYun XiaoXia LiPublished in: Neuropathology and applied neurobiology (2020)
For the first time, we integrated the clonal status of somatic mutations into cancer genomic classification and highlighted the necessity of considering IDH clonal architectures in glioma precision stratification.